Multiple 340B covered entities and consultants say they have hit roadblocks trying to navigate drug manufacturers restrictions on 340B pricing when entities contract with outside pharmacies to dispense 340B drugs.
340B Report Holding May 18 Webinar on Implementing Drug Makers’ New 340B Contract Pharmacy Rules
340B Report, an independent news organization covering the 340B drug pricing program, is holding its first event—a May 18 webinar about implementing drug manufacturers’ controversial new rules on 340B contract pharmacies. It is an exclusive and free benefit for paid subscribers to 340B Report.
Understanding and complying with these first-of-their-kind policies is hard, 340B covered entities say. Getting help also is hard, they add. Two usual advisers to entities on such matters—the federal government and trade associations—believe that what the manufacturers are doing is illegal and they do not want to abet drug makers’ policies. Many entities say, though, that as a practical matter they must comply, and they desperately need guidance.
340B Report is holding its first event—a May 18 webinar about implementing drug manufacturers’ controversial new rules on 340B contract pharmacies.